DailyStocks Stock Article Search

https://www.fool.com/investing/2024/03/07/1-wall-street-analyst-69-upside-nio-stock-buy/?source=iedfolrf0000001 Mar 07, 2024 - Nio expects its sales momentum and margins to pick up pace as 2024 progresses. 0

https://www.entrepreneur.com/growing-a-business/how-dria-murphy-is-transforming-the-wellness-space/470757 Mar 07, 2024 - The founder of Alise Collective and by dria discusses her entrepreneurial journey and why she's so passionate about making people happier and healthier. 0

https://www.zacks.com/stock/news/2236743/wall-street-analysts-see-a-44-13-upside-in-lantheus-holdings-lnth-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2236743 Mar 06, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 44.1% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2236629/wall-street-analysts-see-lantheus-holdings-lnth-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2236629 Mar 06, 2024 - Based on the average brokerage recommendation (ABR), Lantheus Holdings (LNTH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2236632/wall-street-analysts-see-panasonic-corp-pcrfy-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2236632 Mar 06, 2024 - According to the average brokerage recommendation (ABR), one should invest in Panasonic Corp. (PCRFY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://www.rttnews.com/story.aspx?Id=3429912 Mar 05, 2024 - After ending the previous session modestly lower, stocks may see further downside in early trading on Tuesday. The major index futures are currently pointing to initial weakness on Wall Street, with the S&P 500 futures down by 0.4 percent. 0

https://www.zacks.com/stock/news/2235661/dave-buster-s-play-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2235661 Mar 04, 2024 - In the latest trading session, Dave & Buster's (PLAY) closed at $61.30, marking a -1.89% move from the previous day. 0

https://seekingalpha.com/article/4675595-capgemini-good-cost-control-still-seeing-slow-cycles-new-genai-conversations?source=feed_all_articles Mar 03, 2024 - Capgemini is a tech consulting company with a focus on Europe and is preparing for better years driven by solid bookings. Read why CAPMF stock is a Hold. 0

https://www.rttnews.com/story.aspx?Id=3429178 Mar 01, 2024 - Stocks have moved mostly higher during trading on Friday, with the Nasdaq and the S&P 500 on pace to set new record closing highs. The major averages have all moved to the upside, with the tech-heavy Nasdaq leading the advance. The advance by the Nasdaq partly reflects substantial strength among computer hardware stocks following upbeat results from Dell. 0

https://www.zacks.com/stock/news/2234650/wall-street-analysts-see-a-58-85-upside-in-arcutis-biotherapeutics-inc-arqt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2234650 Mar 01, 2024 - The consensus price target hints at a 58.9% upside potential for Arcutis Biotherapeutics, Inc. (ARQT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0